In a report released today, Akash Tewari from Jefferies maintained a Buy rating on Pfizer (PFE – Research Report), with a price target of $34.00. The company’s shares closed yesterday at $22.63.

April 3 (Reuters) - British pharmaceutical giant GlaxoSmithKline (GSK.L), opens new tab and rival Pfizer (PFE.N), opens new tab have agreed to end a lawsuit that alleged Pfizer's respiratory ...

April 1 (Reuters) - The European Commission approved Pfizer's (PFE.N), opens new tab respiratory syncytial virus vaccine for the prevention of lower respiratory tract disease caused by RSV in ...

It’s not HBO, it’s Max — but the new standalone logo for Warner Bros. Discovery‘s streamer now certainly looks like HBO’s at a glance. The Max streaming service has quietly launched a ...

Senator Ron Wyden (D-Ore.), a senior member of the Senate Finance Committee, accused Pfizer (PFE) of carrying out what he described as potentially the biggest tax-dodging scheme in pharmaceutical ...

Will Smith's former teacher received a special shout-out during a street renaming ceremony to honor the actor in Philadelphia. The Academy Award winner was celebrated on Wednesday with the ...

Apple has been reportedly working on a major overhaul of the iOS platform with iOS 19, with VisionOS-like transparency present across the UI, as per Bloomberg’s recent reporting. Now, Apple has ...